Top-News
Gesundheitswesen USA

CytoSorbents News

Aktie
WKN:  A12GDU ISIN:  US23283X2062 US-Symbol:  CTSO
0,836 €
+0,009 €
+1,09%
07.05.24 14:36:11
Handeln Depot/Watchlist
Aktienanzahl *
52,21 Mio.
Marktkapitalisierung *
45,08 Mio. €
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 10.01.2024

CytoSorbents News

30.01.24 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Cytosorbents Corporation - CTSO
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Cytosorbents Corporation - CTSO PR Newswire
22.01.24 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Cytosorbents Corporation - CTSO
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Cytosorbents Corporation - CTSO PR Newswire
14.01.24 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Cytosorbents Corporation - CTSO
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Cytosorbents Corporation - CTSO PR Newswire
06.01.24 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Cytosorbents Corporation - CTSO
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Cytosorbents Corporation - CTSO PR Newswire
29.12.23 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Cytosorbents Corporation - CTSO
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Cytosorbents Corporation - CTSO PR Newswire
05.12.23 - PR Newswire
Thinking about buying stock in Macy's Inc, Altamira Therapeutics, Neurosense Therapeutics, Cytosorbents, or Designer Brands?
Thinking about buying stock in Macy's Inc, Altamira Therapeutics, Neurosense Therapeutics, Cytosorbents, or Designer Brands? PR Newswire
14.08.23 - PR Newswire
CytoSorbents Completes U.S. and Canadian STAR-T Pivotal Trial
CytoSorbents Completes U.S. and Canadian STAR-T Pivotal Trial PR Newswire
27.02.23 - PR Newswire
CytoSorbents to Present at the Cowen 43rd Annual Health Care Conference
CytoSorbents to Present at the Cowen 43rd Annual Health Care Conference PR Newswire
24.02.23 - PR Newswire
CytoSorbents to Report Fiscal 2022 Operating and Financial Results
CytoSorbents to Report Fiscal 2022 Operating and Financial Results PR Newswire
31.01.23 - PR Newswire
CytoSorbents Issues Stockholder Letter and Reports Preliminary Fourth Quarter and Full Year 2022 Revenue
CytoSorbents Issues Stockholder Letter and Reports Preliminary Fourth Quarter and Full Year 2022 Revenue PR Newswire
23.01.23 - PR Newswire
CytoSorbents Announces Health Canada Regulatory Approval For Pivotal STAR-T Trial
CytoSorbents Announces Health Canada Regulatory Approval For Pivotal STAR-T Trial PR Newswire
17.01.23 - PR Newswire
CytoSorbents Appoints Irina B. Kulinets, PhD, as Senior Vice President of Global Regulatory Affairs
CytoSorbents Appoints Irina B. Kulinets, PhD, as Senior Vice President of Global Regulatory Affairs PR Newswire
29.12.22 - PR Newswire
CytoSorbents Receives $5M in Non-Dilutive Debt Financing from Bridge Bank and Extends Loan Agreement
CytoSorbents Receives $5M in Non-​Dilutive Debt Financing from Bridge Bank and Extends Loan Agreement PR Newswire
14.11.22 - PR Newswire
CytoSorbents Announces Pivotal STAR-T Trial Reaches First Milestone With 40 Patients Enrolled
CytoSorbents Announces Pivotal STAR-T Trial Reaches First Milestone With 40 Patients Enrolled PR Newswire
03.11.22 - PR Newswire
CytoSorbents Reports Third Quarter 2022 Financial and Operational Results
CytoSorbents Reports Third Quarter 2022 Financial and Operational Results PR Newswire
02.11.22 - PR Newswire
Thinking about buying stock in Arcturus Therapeutics, Chegg, Match, Yum China, or Cytosorbents?
Thinking about buying stock in Arcturus Therapeutics, Chegg, Match, Yum China, or Cytosorbents? PR Newswire
31.10.22 - PR Newswire
National Institutes of Health Grants Phase I SBIR Award to CytoSorbents to Test Novel Polymers for Cytokine and Endotoxin Removal from Septic Porcine Plasma
National Institutes of Health Grants Phase I SBIR Award to CytoSorbents to Test Novel Polymers for Cytokine and Endotoxin Removal from Septic Porcine Plasma PR Newswire
27.10.22 - PR Newswire
CytoSorbents to Report Third Quarter 2022 Operating and Financial Results
CytoSorbents to Report Third Quarter 2022 Operating and Financial Results PR Newswire
12.10.22 - PR Newswire
CytoSorbents Reports New Cardiac Surgery Data with CytoSorb at the European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting
CytoSorbents Reports New Cardiac Surgery Data with CytoSorb at the European Association for Cardio-​Thoracic Surgery (EACTS) Annual Meeting PR Newswire
07.10.22 - PR Newswire
CytoSorbents Announces Pending Retirement of Chief Financial Officer Kathleen P. Bloch
CytoSorbents Announces Pending Retirement of Chief Financial Officer Kathleen P. Bloch PR Newswire

Newssuche

Videos

newspaper
07.05.24 +43,15%
Technical Trading: DAX Long kurzfristig
DAX Long Typ: Turbo Open End WKN: NG8K9X Hebel: 26 Laufzeit: OpenEnd Einstieg: Market ... Mehr »